Tag: Prices
14th CII Global MedTech Summit: Healthcare sector in India expected to...
Dwelling on the Vision @ 2047, Union Minister Dr Jitendra Singh said, it is expected that India becomes one of the top markets in medical devices upwards of 14% - 15%
ICRA maintains stable outlook for Indian pharma companies
Domestic pharma cos expected to grow at a CAGR of around 10-12% between FY2019-2022. The productivity of R&D expenditure, operational risk related to an increased level of due diligence by regulatory agencies and price controls are key concerns................
Govt to cap prices of medical diagnostics, puts out draft list...
The proposed list of essential diagnostic tests whose prices will be fixed later is available on the Indian Council for Medical Research website for comments till January 31, 2019...............
We don’t support self-regulation proposal of AISNMA, says MTaI
While making its stand clear along with a set of justifications on the reasons behind it, the Medical Technology Association of India has rejected the self-regulation of syringe prices proposed by the All India Syringes and Needles Manufacturers Association....................
Govt says no major impact on prices of essential drugs post...
Government ensuring essential drugs are available to public at reduced prices, mentioned the union MOS-Chemicals and Fertilizers, Mr Mansukh L. Mandaviya................
Determination of ceiling prices of drugs a continuous process: Govt
The Department of Pharmaceuticals, Government of India has rejected the allegations regarding tightening of price control as both misleading and misplaced...........
Govt cracks the whip, fixes ceiling prices of orthopaedic knee implants
While making it clear that overcharging of knee implants would be strictly monitored and penalized, the government has termed the move to cap their prices as a step to ensure affordable and quality healthcare..........
We are watching: govt tells overcharging pharma firms
Demand notices of Rs 74.65 crore issued to pharmaceutical companies for launching drug formulations without prior price approval of NPPA..........
Pharma firms deposit Rs 294.84 crores fine for overcharging patients
The money has been deposited against demand notices issued by the union government for overcharging patients for scheduled medicines...........
Shortage of life saving drugs, govt monitoring situation
Amid complaints over shortage of D-Pencillamine, the health ministry has initiated action on the same and these are being forwarded....